Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.87%
#3 Nockchain Nockchain +22.61%
#4 Fabric Protocol Fabric Protocol +19.38%
#5 Bedrock Bedrock +16.78%
#6 Cysic Cysic +15.00%
#7 Perle Perle +12.14%
#8 Tutorial Tutorial +6.24%
#9 Anvil Anvil +6.20%
#10 Arowana Arowana +6.03%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
BioSenic S.A. BioSenic S.A.

BioSenic S.A.

BIOS
Rank in Stocks #37641
BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium,... BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium, is dedicated to progressing clinical therapeutic solutions. The firm utilizes two primary technology platforms: an innovative allogeneic cell and gene therapy system featuring distinct bone marrow-derived mesenchymal stromal cells designed for convenient on-site hospital storage; and an Arsenic Trioxide platform. The latter is deployed in immuno-oncology to target illnesses such as graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's leading experimental drug, ALLOB, is currently undergoing a Phase IIb clinical trial for patients with complicated tibial fractures.
Share Price
$0.00237231
Last synced: 2026-06-22
Market Cap
$1.55M
Change (1 day)
0.00%
Change (1 year)
-18.94%
Country
BE
Trade BioSenic S.A. (BIOS)

Category

Healthcare
Earnings for BioSenic S.A. (BIOS)
Earnings in 2026 TTM: 0
According to BioSenic S.A. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for BioSenic S.A. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE